A detailed history of Raymond James & Associates transactions in Smith & Nephew PLC stock. As of the latest transaction made, Raymond James & Associates holds 128,854 shares of SNN stock, worth $3.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,854
Previous 47,354 172.11%
Holding current value
$3.26 Million
Previous $1.17 Million 242.03%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$24.51 - $31.64 $2 Million - $2.58 Million
81,500 Added 172.11%
128,854 $4.01 Million
Q2 2024

Jul 19, 2024

BUY
$23.77 - $26.48 $32,137 - $35,800
1,352 Added 2.94%
47,354 $1.17 Million
Q1 2024

Apr 22, 2024

SELL
$25.36 - $28.88 $645,640 - $735,255
-25,459 Reduced 35.63%
46,002 $1.17 Million
Q4 2023

Jan 16, 2024

SELL
$21.55 - $27.43 $11 Million - $14 Million
-511,426 Reduced 87.74%
71,461 $1.95 Million
Q3 2023

Oct 24, 2023

SELL
$24.33 - $31.28 $496,429 - $638,237
-20,404 Reduced 3.38%
582,887 $14.4 Million
Q2 2023

Jul 25, 2023

SELL
$28.08 - $32.7 $6.2 Million - $7.22 Million
-220,882 Reduced 26.8%
603,291 $19.5 Million
Q1 2023

Apr 14, 2023

SELL
$27.29 - $29.4 $3.12 Million - $3.36 Million
-114,192 Reduced 12.17%
824,173 $23 Million
Q4 2022

Feb 08, 2023

SELL
$22.3 - $27.91 $2.69 Million - $3.37 Million
-120,686 Reduced 11.4%
938,365 $25.2 Million
Q3 2022

Oct 25, 2022

BUY
$12.1 - $29.35 $1.65 Million - $4.01 Million
136,587 Added 14.81%
1,059,051 $24.6 Million
Q2 2022

Aug 12, 2022

BUY
$27.53 - $33.71 $1.91 Million - $2.33 Million
69,208 Added 8.11%
922,464 $25.8 Million
Q1 2022

May 11, 2022

BUY
$30.84 - $36.38 $1.64 Million - $1.93 Million
53,176 Added 6.65%
853,256 $27.2 Million
Q4 2021

Feb 08, 2022

BUY
$31.98 - $37.15 $1.98 Million - $2.3 Million
61,860 Added 8.38%
800,080 $27.7 Million
Q3 2021

Nov 02, 2021

BUY
$34.34 - $44.17 $6.46 Million - $8.31 Million
188,179 Added 34.21%
738,220 $25.4 Million
Q2 2021

Aug 11, 2021

SELL
$37.86 - $44.01 $5.05 Million - $5.86 Million
-133,258 Reduced 19.5%
550,041 $23.9 Million
Q1 2021

May 14, 2021

BUY
$36.75 - $45.88 $4.22 Million - $5.27 Million
114,759 Added 20.18%
683,299 $25.9 Million
Q4 2020

Feb 12, 2021

BUY
$35.07 - $42.82 $5.05 Million - $6.16 Million
143,887 Added 33.88%
568,540 $24 Million
Q3 2020

Nov 04, 2020

BUY
$37.35 - $42.16 $1.49 Million - $1.68 Million
39,833 Added 10.35%
424,653 $16.6 Million
Q2 2020

Jul 28, 2020

BUY
$33.79 - $44.24 $4.95 Million - $6.49 Million
146,612 Added 61.55%
384,820 $14.7 Million
Q1 2020

Apr 21, 2020

BUY
$27.78 - $51.64 $1.64 Million - $3.05 Million
59,064 Added 32.97%
238,208 $8.55 Million
Q4 2019

Feb 12, 2020

BUY
$42.26 - $48.5 $5.22 Million - $5.99 Million
123,424 Added 221.51%
179,144 $8.61 Million
Q3 2019

Nov 07, 2019

BUY
$43.17 - $48.59 $227,462 - $256,020
5,269 Added 10.44%
55,720 $2.68 Million
Q2 2019

Aug 06, 2019

BUY
$37.82 - $43.93 $354,373 - $411,624
9,370 Added 22.81%
50,451 $2.2 Million
Q1 2019

May 06, 2019

SELL
$35.51 - $40.32 $331,556 - $376,467
-9,337 Reduced 18.52%
41,081 $1.65 Million
Q4 2018

Feb 11, 2019

BUY
$32.4 - $38.6 $71,895 - $85,653
2,219 Added 4.6%
50,418 $1.89 Million
Q3 2018

Nov 14, 2018

BUY
$35.11 - $37.52 $583,247 - $623,282
16,612 Added 52.59%
48,199 $1.79 Million
Q2 2018

Aug 14, 2018

BUY
$35.44 - $39.44 $74,742 - $83,178
2,109 Added 7.15%
31,587 $1.19 Million
Q1 2018

May 14, 2018

BUY
$34.12 - $38.45 $115,735 - $130,422
3,392 Added 13.0%
29,478 $1.13 Million
Q4 2017

Feb 14, 2018

BUY
$34.62 - $38.5 $168,737 - $187,649
4,874 Added 22.98%
26,086 $913,000
Q3 2017

Nov 13, 2017

BUY
$34.99 - $37.17 $390,383 - $414,705
11,157 Added 110.96%
21,212 $772,000
Q2 2017

Aug 14, 2017

BUY
N/A
10,055
10,055 $350,000

Others Institutions Holding SNN

About SMITH & NEPHEW PLC


  • Ticker SNN
  • Exchange OTC
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 435,348,000
  • Market Cap $11B
  • Description
  • Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...
More about SNN
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.